Perhaps, RLFTF did the right thing. “With th
Post# of 148163
“With the improvement in survival since the start of the pandemic, differences in patient survival were not seen at day 28, and patients are now being followed through day 60."
CYDY may yet face the same situation and appreciate the wisdom of the DCMS recommending following our results through day 42.
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.